Literature DB >> 25777348

BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer.

Nagi S El Saghir1, Nathalie K Zgheib2, Hussein A Assi2, Katia E Khoury2, Yannick Bidet2, Sara M Jaber2, Raghid N Charara2, Rania A Farhat2, Firas Y Kreidieh2, Stephanie Decousus2, Pierre Romero2, Georges M Nemer2, Ziad Salem2, Ali Shamseddine2, Arafat Tfayli2, Jaber Abbas2, Faek Jamali2, Muhieddine Seoud2, Deborah K Armstrong2, Yves-Jean Bignon2, Nancy Uhrhammer2.   

Abstract

PURPOSE: Breast cancer is the most common malignancy among women in Lebanon and in Arab countries, with 50% of cases presenting before the age of 50 years.
METHODS: Between 2009 and 2012, 250 Lebanese women with breast cancer who were considered to be at high risk of carrying BRCA1 or BRCA2 mutations because of presentation at young age and/or positive family history (FH) of breast or ovarian cancer were recruited. Clinical data were analyzed statistically. Coding exons and intron-exon boundaries of BRCA1 and BRCA2 were sequenced from peripheral blood DNA. All patients were tested for BRCA1 rearrangements using multiplex ligation-dependent probe amplification (MLPA). BRCA2 MLPA was done in selected cases.
RESULTS: Overall, 14 of 250 patients (5.6%) carried a deleterious BRCA mutation (7 BRCA1, 7 BRCA2) and 31 (12.4%) carried a variant of uncertain significance. Eight of 74 patients (10.8%) aged ≤40 years with positive FH and only 1 of 74 patients (1.4%) aged ≤40 years without FH had a mutated BRCA. Four of 75 patients (5.3%) aged 41-50 years with FH had a deleterious mutation. Only 1 of 27 patients aged >50 years at diagnosis had a BRCA mutation. All seven patients with BRCA1 mutations had grade 3 infiltrating ductal carcinoma and triple-negative breast cancer. Nine BRCA1 and 17 BRCA2 common haplotypes were observed.
CONCLUSION: Prevalence of deleterious BRCA mutations is lower than expected and does not support the hypothesis that BRCA mutations alone cause the observed high percentage of breast cancer in young women of Lebanese and Arab descent. Studies to search for other genetic mutations are recommended. ©AlphaMed Press.

Entities:  

Keywords:  Arab countries; BRCA mutations; Breast cancer; Family history; Haplotype; Lebanon; Young age

Mesh:

Substances:

Year:  2015        PMID: 25777348      PMCID: PMC4391767          DOI: 10.1634/theoncologist.2014-0364

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  29 in total

1.  Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection.

Authors:  Safinaz S Ibrahim; Elsayed E Hafez; Mervat M Hashishe
Journal:  J Exp Clin Cancer Res       Date:  2010-06-25

2.  BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.

Authors:  Kathryn Alsop; Sian Fereday; Cliff Meldrum; Anna deFazio; Catherine Emmanuel; Joshy George; Alexander Dobrovic; Michael J Birrer; Penelope M Webb; Colin Stewart; Michael Friedlander; Stephen Fox; David Bowtell; Gillian Mitchell
Journal:  J Clin Oncol       Date:  2012-06-18       Impact factor: 44.544

3.  BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors.

Authors:  Khalid Dafaallah Awadelkarim; Gitana Aceto; Serena Veschi; Ahmed Elhaj; Annalisa Morgano; Ahmed Abdalla Mohamedani; Elgaylani Abdalla Eltayeb; Dafaallah Abuidris; Mario Di Gioacchino; Pasquale Battista; Fabio Verginelli; Alessandro Cama; Nasr Eldin Elwali; Renato Mariani-Costantini
Journal:  Breast Cancer Res Treat       Date:  2007-03-01       Impact factor: 4.872

4.  Lack of association of BRCA1 and BRCA2 variants with breast cancer in an ethnic population of Saudi Arabia, an emerging high-risk area.

Authors:  Tarique Noorul Hasan; Gowhar Shafi; Naveed Ahmed Syed; Mohammed Abdullah Alsaif; Abdulaziz Abdullah Alsaif; Ali Abdullah Alshatwi
Journal:  Asian Pac J Cancer Prev       Date:  2013

5.  Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998.

Authors:  Ali Shamseddine; Abla-Mehio Sibai; Nageeb Gehchan; Boushra Rahal; Nagi El-Saghir; Marwan Ghosn; Georges Aftimos; Nabil Chamsuddine; Muhieddine Seoud
Journal:  Ann Epidemiol       Date:  2004-10       Impact factor: 3.797

6.  Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.

Authors:  Laurent Castéra; Sophie Krieger; Antoine Rousselin; Angélina Legros; Jean-Jacques Baumann; Olivia Bruet; Baptiste Brault; Robin Fouillet; Nicolas Goardon; Olivier Letac; Stéphanie Baert-Desurmont; Julie Tinat; Odile Bera; Catherine Dugast; Pascaline Berthet; Florence Polycarpe; Valérie Layet; Agnes Hardouin; Thierry Frébourg; Dominique Vaur
Journal:  Eur J Hum Genet       Date:  2014-02-19       Impact factor: 4.246

7.  Variation in mutation spectrum partly explains regional differences in the breast cancer risk of female BRCA mutation carriers in the Netherlands.

Authors:  Janet R Vos; Natalia Teixeira; Dorina M van der Kolk; Marian J E Mourits; Matti A Rookus; Flora E van Leeuwen; Margriet Collée; Christi J van Asperen; Arjen R Mensenkamp; Margreet G E M Ausems; Theo A M van Os; Hanne E J Meijers-Heijboer; Encarna B Gómez-Garcia; Hans F Vasen; Richard M Brohet; Annemarie H van der Hout; Liesbeth Jansen; Jan C Oosterwijk; Geertruida H de Bock
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-07       Impact factor: 4.254

8.  Effects of young age at presentation on survival in breast cancer.

Authors:  Nagi S El Saghir; Muhieddine Seoud; Mazen K Khalil; Maya Charafeddine; Ziad K Salem; Fady B Geara; Ali I Shamseddine
Journal:  BMC Cancer       Date:  2006-07-20       Impact factor: 4.430

9.  Breast-cancer risk in families with mutations in PALB2.

Authors:  Antonis C Antoniou; Silvia Casadei; Tuomas Heikkinen; Daniel Barrowdale; Katri Pylkäs; Jonathan Roberts; Andrew Lee; Deepak Subramanian; Kim De Leeneer; Florentia Fostira; Eva Tomiak; Susan L Neuhausen; Zhi L Teo; Sofia Khan; Kristiina Aittomäki; Jukka S Moilanen; Clare Turnbull; Sheila Seal; Arto Mannermaa; Anne Kallioniemi; Geoffrey J Lindeman; Saundra S Buys; Irene L Andrulis; Paolo Radice; Carlo Tondini; Siranoush Manoukian; Amanda E Toland; Penelope Miron; Jeffrey N Weitzel; Susan M Domchek; Bruce Poppe; Kathleen B M Claes; Drakoulis Yannoukakos; Patrick Concannon; Jonine L Bernstein; Paul A James; Douglas F Easton; David E Goldgar; John L Hopper; Nazneen Rahman; Paolo Peterlongo; Heli Nevanlinna; Mary-Claire King; Fergus J Couch; Melissa C Southey; Robert Winqvist; William D Foulkes; Marc Tischkowitz
Journal:  N Engl J Med       Date:  2014-08-07       Impact factor: 91.245

10.  BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases.

Authors:  Nancy Uhrhammer; Amina Abdelouahab; Laurence Lafarge; Viviane Feillel; Ahmed Ben Dib; Yves-Jean Bignon
Journal:  Int J Med Sci       Date:  2008-07-08       Impact factor: 3.738

View more
  30 in total

Review 1.  Familial/inherited cancer syndrome: a focus on the highly consanguineous Arab population.

Authors:  Fawz S AlHarthi; Alya Qari; Alaa Edress; Malak Abedalthagafi
Journal:  NPJ Genom Med       Date:  2020-02-03       Impact factor: 8.617

2.  Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP53.

Authors:  Suhair Lolas Hamameh; Paul Renbaum; Lara Kamal; Dima Dweik; Mohammad Salahat; Tamara Jaraysa; Amal Abu Rayyan; Silvia Casadei; Jessica B Mandell; Suleyman Gulsuner; Ming K Lee; Tom Walsh; Mary-Claire King; Ephrat Levy-Lahad; Moein Kanaan
Journal:  Int J Cancer       Date:  2017-05-19       Impact factor: 7.396

3.  Recurrent TP53 missense mutation in cancer patients of Arab descent.

Authors:  Aviad Zick; Luna Kadouri; Sherri Cohen; Michael Frohlinger; Tamar Hamburger; Naama Zvi; Morasha Plaser; Eilat Avital; Shani Breuier; Firase Elian; Azzam Salah; Yael Goldberg; Tamar Peretz
Journal:  Fam Cancer       Date:  2017-04       Impact factor: 2.375

4.  Genetic Counseling, Screening and Risk-Reducing Surgery in Patients with Primary Breast Cancer and Germline BRCA Mutations: Unmet Needs in Low- and Middle-Income Countries.

Authors:  Hiba A Moukadem; Ahmad Al Masry; Rula W Atwani; Firas Kreidieh; Lana E Khalil; Rita Saroufim; Sarah Daouk; Iman Abou Dalle; Nagi S El Saghir
Journal:  Eur J Breast Health       Date:  2021-12-30

5.  A recurrent pathogenic BRCA2 exon 5-11 duplication in the Christian Arab population in Israel.

Authors:  Hagit Baris-Feldman; Karin Weiss; Gili Reznick Levi; Gal Larom; Vered Ofen Glassner; Nina Ekhilevitch; Nitzan Sharon Swartzman; Tamar Paperna
Journal:  Fam Cancer       Date:  2021-05-17       Impact factor: 2.446

6.  Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer.

Authors:  Wen-Ming Cao; Yun Gao; Hong-Jian Yang; Shang-Nao Xie; Xiao-Wen Ding; Zhi-Wen Pan; Wei-Wu Ye; Xiao-Jia Wang
Journal:  BMC Cancer       Date:  2016-02-06       Impact factor: 4.430

7.  Characteristics of BRCA1/2 mutations carriers including large genomic rearrangements in high risk breast cancer patients.

Authors:  Boyoung Park; Ji Yeon Sohn; Kyong-Ah Yoon; Keun Seok Lee; Eun Hae Cho; Myong Cheol Lim; Moon Jung Yang; Soo Jin Park; Moo Hyun Lee; See Youn Lee; Yoon Jung Chang; Dong Ock Lee; Sun-Young Kong; Eun Sook Lee
Journal:  Breast Cancer Res Treat       Date:  2017-02-15       Impact factor: 4.872

8.  Sociological Transition and Breast Cancer in the Arab World: the Experience of Lebanon

Authors:  Najla A Lakkis; Salim M Adib; Ghassan Hamadeh; Rana El Jarrah; Mona H Osman
Journal:  Asian Pac J Cancer Prev       Date:  2017-05-01

9.  Patterns and Prevalence of BRCA1 and BRCA2 Germline Mutations Among Patients with Triple-Negative Breast Cancer: Regional Perspectives.

Authors:  Hikmat Abdel-Razeq; Faris Tamimi; Lama Abujamous; Sara Edaily; Mahmoud Abunasser; Rayan Bater; Osama Salama
Journal:  Cancer Manag Res       Date:  2021-06-09       Impact factor: 3.989

10.  Younger age is an independent predictor of worse prognosis among Lebanese nonmetastatic breast cancer patients: analysis of a prospective cohort.

Authors:  Alissar El Chediak; Raafat S Alameddine; Ayman Hakim; Lara Hilal; Sarah Abdel Massih; Lana Hamieh; Deborah Mukherji; Sally Temraz; Maya Charafeddine; Ali Shamseddine
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.